Tuberculosis in 2015: From diagnosis to the detection of multiresistant cases;La tuberculose en 2015: du diagnostic à la détection des formes résistantes

Revue des Maladies Respiratoires

Volumn 32, Issue 8, 2015, Pages 784-790

  Herve C ^a   Bergot, E ^b   Veziris, N ^c   Blanc, F X ^a  

^a CHU de Nantes   (France)

^b CAEN UNIVERSITY HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Diagnosis; Drug resistance; Genotype; Phenotype; Tuberculosis

Indexed keywords

BEDAQUILINE; RIFAMPICIN; ATP SYNTHASE SUBUNIT C, MYCOBACTERIUM TUBERCULOSIS; BACTERIAL DNA; BACTERIAL PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; QUINOLINE DERIVATIVE; TUBERCULOSTATIC AGENT;

ARTICLE; DRUG RESISTANT TUBERCULOSIS; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; HUMAN; INCIDENCE; LUNG TUBERCULOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION; QT PROLONGATION; ANTAGONISTS AND INHIBITORS; FRANCE; GENETICS; GENOTYPING TECHNIQUE; INTERFERON GAMMA RELEASE ASSAY; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; BACTERIAL PROTON-TRANSLOCATING ATPASES; DIARYLQUINOLINES; DNA, BACTERIAL; FRANCE; GENOTYPING TECHNIQUES; HUMANS; INCIDENCE; INTERFERON-GAMMA RELEASE TESTS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHENOTYPE; PREDICTIVE VALUE OF TESTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULIN TEST; TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84946497356     PISSN: 07618425     EISSN: 17762588     Source Type: Journal    
DOI: 10.1016/j.rmr.2015.06.008     Document Type: Review

References (42)

1. Aït Belghiti F, Antoine D. L'épidémiologie de la tuberculose en France en 2013;2015:164-71.
2. Steingart KR, Ng V, Henry M, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006;6:664-74.
3. Guillet-Caruba C, Martinez V, Doucet-Populaire F. Les nouveaux outils de diagnostic microbiologique de la tuberculose maladie. Rev Med Interne 2014;35:794-800.
4. Haut Conseil de la Santé Publique [93 pages] Enquête autour d'un cas de tuberculose. Recommandations pratiques; 2013 [Dernier accès le 8 mars 2015] http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=391
5. Kim TC, Blackman RS, Heatwole KM, et al. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment. Am Rev Respir Dis 1984;129:264-8.
6. Levy H, Feldman C, Sacho H, et al. A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis. Chest 1989;95:1193-7.
7. Klein NC, Duncanson FP, Lenox TH, et al. Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients. Chest 1989;95:1190-2.
8. Gordin F, Slutkin G. The validity of acid-fast smears in the diagnosis of pulmonary tuberculosis. Arch Pathol Lab Med 1990;114:1025-7.
9. Aktogu S, Yorgancioglu A, Cirak K, et al. Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5,480 cases. Eur Respir J 1996;9:2031-5.
10. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010;363:1005-15.
11. Yoon SH, Lee NK, Yim JJ. Impact of sputum gross appearance and volume on smear positivity of pulmonary tuberculosis: a prospective cohort study. BMC Infect Dis 2012;12:172.
12. Mase SR, Ramsay A, Ng V, et al. Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2007;11:485-95.
13. Steingart KR, Schiller I, Horne DJ, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2014;1:CD009593.
14. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011;377:1495-505.
15. Salzman SH, Schindel ML, Aranda CP, et al. The role of bronchoscopy in the diagnosis of pulmonary tuberculosis in patients at risk for HIV infection. Chest 1992;102:143-6.
16. Lee HY, Seong MW, Park SS, et al. Diagnostic accuracy of Xpert® MTB/RIF on bronchoscopy specimens in patients with suspected pulmonary tuberculosis. Int J Tuberc Lung Dis 2013;17:917-21.
17. Le Palud P, Cattoir V, Malbruny B, et al. Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis. BMC Pulm Med 2014;14:137.
18. Sester M, Sotgiu G, Lange C, et al. Interferon-gamma release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J 2011;37:100-11.
19. Hassan T, McLaughlin AM, O'Connell F, et al. EBUS-TBNA performs well in the diagnosis of isolated thoracic tuberculous lymphadenopathy. Am J Respir Crit Care Med 2011;183:136-7.
20. Dhasmana DJ, Ross C, Bradley CJ, et al. Performance of Xpert MTB/RIF in the diagnosis of tuberculous mediastinal lymphadenopathy by endobronchial ultrasound. Ann Am Thorac Soc 2014;11:392-6.
21. Epstein DM, Kline LR, Albelda SM, et al. Tuberculous pleural effusions. Chest 1987;91:106-9.
22. Querol JM, Minguez J, Garcia-Sanchez E, et al. Rapid diagnosis of pleural tuberculosis by polymerase chain reaction. Am J Respir Crit Care Med 1995;152:1977-81.
23. Villegas MV, Labrada LA, Saravia NG. Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest 2000;118:1355-64.
24. Conde MB, Loivos AC, Rezende VM, et al. Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med 2003;167:723-5.
25. Denkinger CM, Schumacher SG, Boehme CC, et al. Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur Respir J 2014;44:435-46.
26. Lusiba JK, Nakiyingi L, Kirenga BJ, et al. Evaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB setting. PLoS One 2014;9:e102702.
27. World Health Organization[Dernier accès le 8 mars] http://www.who.int/tb/publications/global-report/gtbr14-main-text.pdf
28. Parrish N, Carrol K. Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis. Future Microbiol 2008;3:405-13.
29. Lin SY, Desmond E, Bonato D, et al. Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex. J Clin Microbiol 2009;47:3630-4.
30. Chang KC, Yew WW, Zhang Y. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses. Antimicrob Agents Chemother 2011;55:4499-505.
31. Zhang Y, Yew WW. Mechanisms of drug resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009;13:1320-30.
32. Brossier F, Veziris N, Jarlier V, et al. Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int J Tuberc Lung Dis 2009;13: 260-5.
33. Ling DI, Zwerling AA, Pai M. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur Respir J 2008;32:1165-74.
34. Ignatyeva O, Kontsevaya I, Kovalyov A, et al. Detection of resistance to second- line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study. J Clin Microbiol 2012;50:1593-7.
35. Jamieson FB, Guthrie JL, Neemuchwala A, et al. Profiling of rpoB mutations and MICs for rifampin and rifabutin in Mycobacterium tuberculosis. J Clin Microbiol 2014;52:2157-62.
36. Diacon AH, Pym A, Grobusch M, et al. The diarylquinoline TMC207 for multidrug- resistant tuberculosis. N Engl J Med 2009;360:2397-405.
37. Diacon AH, Pym A, Grobusch MP, et al. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med 2014;371:723-32.
38. Guglielmetti L, Le du D, Jachym M, et al. Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort. Clin Infect Dis 2015;60:188-94.
39. Somoskovi A, Bruderer V, Homke R, et al. A mutation associated with clofazimine and bedaquiline cross-resistance in MDR-TB following bedaquiline treatment. Eur Respir J 2015;45: 554-7.
40. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA 1993;270:65- 8.
41. Bwanga F, Hoffner S, Haile M, et al. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009;9:67.
42. CNR-MyRMA. Résistance aux antituberculeux en France en 2013. Bull Epidemiol Hebd 2015:172-4.